US9951083B2ActiveUtilityPatentIndex 84
Cyclopamine analogs
Assignee: INFINITY PHARMACEUTICALS INCPriority: Dec 28, 2006Filed: Oct 10, 2016Granted: Apr 24, 2018
Est. expiryDec 28, 2026(~0.5 yrs left)· nominal 20-yr term from priority
Inventors:AUSTAD BRIANBEHNKE MARK LCASTRO ALFREDO CGROGAN MICHAEL JJANARDANANNAIR SOMARAJANNAIRLESCARBEAU ANDREPELUSO STEPHANECHARETTE ANDRE BTREMBLAY MARTIN R
A61P 35/00A61P 43/00A61P 35/04A61P 35/02C07D 491/04C07J 69/00A61K 31/198A61K 31/7068C07D 491/107A61K 31/58A61K 31/573C07D 491/10A61K 31/7076A61K 31/17A61K 31/664A61K 31/69C07D 471/10A61K 31/4745A61K 31/56A61K 45/06A61K 31/454A61K 31/704C07D 307/94A61K 31/4355A61K 31/196C07D 471/04A61K 38/21A61K 31/519A61N 5/10C07D 491/048A61K 9/0014A61K 31/4747A61K 31/4741
84
PatentIndex Score
4
Cited by
515
References
19
Claims
Abstract
The invention provides derivatives of cyclopamine having the following formula:
Claims
exact text as granted — not AI-modifiedIt is claimed:
1. A process for preparing a compound of formula 136:
wherein
Y is CR 7 R 8 ;
R 1 is H, alkyl, amino, hydroxyl, carboxyl, carbamoyl, alkoxy, hydroxyl, sugar or a protected hydroxyl group; R 2 is H, alkyl, alkenyl, alkynyl, nitrile, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, or heteroaralkyl; or R 1 and R 2 taken together form ═O, ═S, ═N(OR 9 ), ═N(R 9 ), ═C(R 9 ) 2 , or ═N(N(R 9 ) 2 );
each of R 3 , R 4 , and R 5 is, independently, H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, or heteroaralkyl; or R 3 and R 4 or R 4 and R 5 taken together form a bond;
R 6 is H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, —OR 9 , —C(O)R 9 , —CO 2 R 9 , —SO 2 R 9 , —C(O)N(R 9 )(R 9 ), —[C(R 9 ) 2 ] q R 9 , —[(W)—N(R 9 )C(O)] q R 9 , —[(W)—C(O)]R 9 , —[(W)—C(O)O] q R 9 , —[(W)—OC(O)] q R 9 , —[(W)—SO 2 ] q R 9 , —[(W)—N(R 9 )SO 2 ] q R 9 , —[(W)—C(O)N(R 9 )] q R 9 , —[(W)—O] q R 9 , —[(W)—N(R 9 )] q R 9 , —[(W)—S] q R 9 , or a nitrogen protecting group;
each W independently for each occurrence is a diradical;
each q is independently 1, 2, 3, 4, 5, or 6;
each of R 7 and R 8 is, independently, H, alkyl, alkenyl, aryl, nitrile, amido, halide, or ester; and
each R 9 is, independently, H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, or heteroaralkyl;
said process comprising the steps of:
contacting a compound of formula 136a with a haloalkylzinc phosphate cyclopropanating agent;
wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 are as defined above;
to form said compound of formula 136;
where said haloalkylzinc phosphate cyclopropanating agent is formed by combining a phosphoric acid of formula 141a, a dialkylzinc, and a dihaloalkylane of formula 141b:
wherein
each of X and X′ is independently chloride, bromide, or iodide;
each of R 7 and R 8 is independently alkyl, alkenyl, aralkyl, aryl, heteroaryl, heteroaralkyl; or R 10 and R 11 taken together have the formula 141c or 141d;
wherein
m independently for each occurrence is 0, 1, 2, 3, or 4; and
each of R 12 , R 13 , and R 14 , is, independently, alkyl, aryl, aralkyl, or halide.
2. The process of claim 1 , wherein R 7 and R 8 are both H.
3. The process of claim 1 , wherein R 1 is a protected hydroxyl.
4. The process of claim 1 , wherein R 6 is a nitrogen protecting group.
5. The process of claim 1 wherein R 10 and R 11 are each 2,6-dimethylphenyl.
6. A process for preparing a compound of formula 137:
wherein
Y is CR 7 R 8 ;
R 1 is H, alkyl, amino, hydroxyl, carboxyl, carbamoyl, alkoxy, hydroxyl, sugar or a protected hydroxyl group; R 2 is H, alkyl, alkenyl, alkynyl, nitrile, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, or heteroaralkyl; or R 1 and R 2 taken together form ═O, ═S, ═N(OR 9 ), ═N(R 9 ), ═C(R 9 ) 2 , or ═N(N(R 9 ) 2 );
each of R 3 , R 4 , and R 5 is, independently, H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, or heteroaralkyl; or R 3 and R 4 or R 4 and R 5 taken together form a bond;
R 6 is H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, heteroaralkyl, haloalkyl, —OR 9 , —C(O)R 9 , —CO 2 R 9 , —SO 2 R 9 , —C(O)N(R 9 )(R 9 ), —[C(R 9 ) 2 ] q R 9 , —[(W)—N(R 9 )C(O)] q R 9 , —[(W)—C(O)] q R 9 , —[(W)—C(O)O] q R 9 , —[(W)—OC(O)] q R 9 , —[(W)—SO 2 ] q R 9 , —[(W)—N(R 9 )SO 2 ] q R 9 , —[(W)—C(O)N(R 9 )] q R 9 , —[(W)—O] q R 9 , —[(W)—N(R 9 )] q R 9 , —[(W)—S] q R 9 , or a nitrogen protecting group;
each W independently for each occurrence is a diradical alkylene having 1-6 carbon atoms;
each q is independently 1, 2, 3, 4, 5, or 6;
each of R 7 and R 8 is, independently, H, alkyl, alkenyl, aryl, nitrile, amido, halide, or ester;
each R 9 is independently H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, or heteroaralkyl;
said process comprising the steps of:
contacting a compound of formula 137a with a haloalkylzinc phosphate cyclopropanating agent;
wherein
R 1 , R 2 , R 3 , R 4 , R 5 , R 6 are as defined above;
to form a compound with formula 137b
wherein
R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and Y are as defined above; and
contacting said compound of formula 137b with an acid to give said compound of formula 137;
where said haloalkylzinc phosphate cyclopropanating agent is formed by combining a phosphoric acid formula 141a, a dialkylzinc, and a dihaloalkylane of formula 141b:
wherein
each of X and X′ is independently chloride, bromide, or iodide;
each of R 7 and R 8 is independently H, alkyl, halide, amido, or ester;
each of R 10 and R 11 is independently alkyl, aralkyl, aryl, heteroaryl, heteroaralkyl; or R 10 and R 11 taken together have the formula 141c or 141d;
wherein
m independently for each occurrence is 0, 1, 2, 3, or 4; and
each of R 12 , R 13 , and R 14 , is, independently, alkyl, aryl, arakyl, or halide.
7. The process of claim 6 ,
wherein
R 1 is a protected hydroxyl group;
R 2 is H, alkyl, alkenyl, alkynyl, aryl, cycloalkyl, heterocycloalkyl, aralkyl, heteroaryl, or heteroaralkyl; and
R 6 is a nitrogen protecting group.
8. The process of claim 6 wherein R 7 and R 8 are both H.
9. The process of claim 7 , wherein said protected hydroxyl group is an ester or a carbonate.
10. The process of claim 7 , wherein said nitrogen protecting group is a carbamate.
11. The process of claim 7 , wherein said nitrogen protecting group is an amide.
12. The process of claim 6 , wherein R 2 and R 3 are H and R 4 and R 5 taken together form a bond.
13. The process of claim 6 , wherein said acid is acetic acid, trifluoromethanesulfonic acid, phosphoric acid, methanesulfonic acid or HCl.
14. The process of claim 6 , wherein said acid is BF 3 , zinc chloride, zinc methanesulfonate, or a zinc salt.
15. A process for preparing a compound of formula 156:
comprising the steps of:
contacting a compound of formula 156a with a haloalkylzinc phosphate cyclopropanating agent to form a compound formula 156b;
and combining said compound of formula 156b with an acid to give said compound of formula 156;
wherein
R 1 is an oxygen protecting group selected from the group consisting of formate, acetate, chloroacetate, dichloroacetate, trichloroacetate, pivaloate, benzoates, alkyl carbonate, alkenyl carbonate, aryl carbonates, aralkyl carbonate, 2,2,2-trichloroethyl carbonate, alkoxymethyl ether, aralkoxymethyl ether, alkylthiomethyl ether, aralkylthio ether, arylthio ether, trialkylsilyl ether, alkylarylsilyl ether, benzyl ether, arylmethyl ether, allyl ether; and
R 2 is a nitrogen protecting group selected from the group consisted of formyl, chloroacetyl, trichloroacetyl, trifluoroacetyl, phenyl acetyl, benzoyl, alkyl carbamates, aralkyl carbamates, aryl carbamates, allyl, aralkyl, triarylmethyl, alkoxymethyl, aralkoxymethyl, N-2-cyanoethyl, diarylphosphinamides, dialkylphosphinamidates, diarylphosphinamidates, and trialkylsilyl,
where said haloalkylzinc phosphate cyclopropanating agent is formed by combining a phosphoric acid of formula 141a, a dialkylzinc, and a dihaloalkylane of formula 141b:
wherein
each of X and X′ is independently chloride, bromide, or iodide;
each of R 7 and R 8 is independently H, alkyl, halide, amido, or ester;
each of R 10 and R 11 is independently alkyl, aralkyl, aryl, heteroaryl, heteroaralkyl; or R 10 and R 11 taken together have the formula 141c or 141d;
wherein
m independently for each occurrence is 0, 1, 2, 3, or 4; and
each of R 12 , R 13 , and R 14 , is, independently, alkyl, aryl, arakyl, or halide.
16. The process of claim 15 , wherein said oxygen protecting group is alkyl carbonate, aralkyl carbonate, benzoate, pivaloate, or formate.
17. The process of claim 15 , wherein said nitrogen protecting group is benzoyl, trichloroacetyl, trifluoroacetyl, formyl, alkyl carbamates, aralkyl carbamates, or aryl carbamates.
18. The process of claim 15 , wherein said oxygen protecting group is benzylcarbonate.
19. The process of claim 15 , wherein said nitrogen protecting group is benzylcarbamate.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.